Isolation of a cDNA clone for the human muscle specific carbonic anhydrase, CAIII

The molecular cloning of cDNA for the human muscle specific carbonic anhydrase CAIII is described. The recombinant was isolated from a human muscle cDNA library prepared in the expression vector Λgt11, and was characterized by hybridization selection and immunoprecipitation. A comparison of insert cDNA and mRNA sizes suggests that the cDNA is full length and includes extensive untranslated sequences. Preliminary sequence data have confirmed the authenticity of this clone and Southern blotting of human and rodent DNA indicates that it will be a useful probe in the analysis of somatic cell hybrids.     

小鼠巨噬细胞cDNA酵母表达文库的构建与鉴定

目的 采用Gateway技术构建适合酵母表达的小鼠巨噬细胞cDNA文库并进行鉴定.方法 将小鼠巨噬细胞的mRNA分离纯化后,以生物素标记的寡聚胸苷酸Oligo(dT)为引物反转录后连接attB衔接子(attB Adapter),层析柱纯化,通过BP重组反应将500 bp以上的片段克隆到含attP衔接子的pDONRTM222载体,电转化入ElectroMAXTM DH10BTMT1 Phage Resistant Cells,构建Gateway入门cDNA文库,并完全随机挑取单菌落,提取质粒酶切鉴定重组子插入片段大小.构建Gateway目的 载体,通过LR重组反应将入门文库转入此目的 载体成为酵母表达文库,挑取单克隆鉴定重组子插入片段大小.结果 经鉴定,入门文库平均滴度为(6.80±0.10)×105 cfu/ml,文库总容量为7.48×106 cfu,平均插入片段为(2.20±0.20)kb,重组率为100%.酵母表达文库平均滴度为(3.24±0.10)×106 cfu/ml,文库总容量为3.89×107 cfu,平均插入的片段为(2.27±0.15)kb,重组率为95.83%(23/24).结论 构建的小鼠巨噬细胞cDNA入门文库和酵母表达文库都符合高质量文库的要求,可用于进一步的研究.     

cDNA cloning of the constant region genes of the guinea pig alpha/beta T-cell receptor.

A lambda gt11 cDNA library was prepared from activated guinea pig T-lymphocyte blasts. cDNA clones coding for the alpha-chain and beta-chain of the constant region of the guinea pig T-cell receptor were isolated by means of crosshybridization using the corresponding mouse cDNA genes. The guinea pig and the corresponding mouse cDNA genes hybridized in Northern blots with mouse mRNA of the same size. Guinea pig T-cell receptor mRNA showed the same size like its mouse counterpart. In contrast to the alpha-chain clone, genomic Southern blot analysis showed that the identified beta-chain gene fragment undergoes genomic rearrangement during T-cell differentiation.     

小鼠脑14-3-3蛋白ζ亚型cDNA克隆及其原核表达分析

14-3-3是一类脑中丰富存在的蛋白质。在许多神经疾病患者的脑脊液中含量升高。最近的研究显示该蛋白相关于Parkinson病的病理过程。本研究采用RT-PCR法从小鼠脑中分离出编码14-3-3ζ亚型的cDNA片段,构建了基因重组质粒,分析了14-3-3ζ亚型cDNA在原核细胞中的表达并制备了基因重组蛋白。结果显示,RT-PCR扩增产物为738bp,编码245个氨基酸。重组质粒在原核细胞中的表达受IPTG诱导呈时间依赖性递增。纯化的目的蛋白在SDS-PAGE中的表观分子量为32kD,在Su-perdexS-200HR中的表观分子量为96kD。每升菌液可收获目的蛋白4.0mg。研究结果提示,14-3-3ζ亚型cDNA在原核细胞中高水平表达,基因重组蛋白易纯化可用于制备抗体和研究其生理功能。     

Expression of amyloid beta-protein gene in Alzheimer's disease

Deposition of amyloid beta-protein in senile plaque cores and cerebral vessels is a major neuropathological finding of Alzheimer's disease (AD). Three species of cDNA clones encoding amyloid beta-protein precursors (APP 695, APP 751 and APP 770) were isolated and sequenced. We examined quantitatively the expression of these APP mRNAs in autopsied brains (frontal cortex) of AD patients and control subjects, using Northern blot analysis and the ribonuclease protection assay. Northern blot analysis revealed the production of three types of APP mRNA in the human brain and that AD/control ratios were 2.04 for APP 770 mRNA, 1.11 for APP 751 mRNA and 1.12 for APP 695 mRNA. In the protection assay the ratio of APP 770/APP 751/APP 695 mRNA was approximately 1:10:20 in the brain of control and the AD/control ratios were 2.38, 1.30 and 0.81 for APP 770, APP 751 and APP 695 mRNAs, respectively. These results suggested that an increase in APP 770 and APP 751, harboring a protease inhibitor domain, may disturb the balance between biosynthesis and degradation of APPs, which might lead to amyloid deposition.     

Cloning of a cDNA encoding a putative human very low density lipoprotein/apolipoprotein E receptor and assignment of the gene to chromosome 9pter-p23

We report the cloning of a 3656-bp cDNA encoding a putative human very low density lipoprotein (VLDL)/apolipoprotein E (ApoE) receptor. The gene encoding this protein was mapped to chromosome 9pter-p23. Northern analysis of human RNA identified cognate mRNAs of 6.0 and 3.8 kb with most abundant expression in heart and skeletal muscle, followed by kidney, placenta, pancreas, and brain. The pattern of expression generally paralleled that of lipoprotein lipase mRNA but differed from that of the low density lipoprotein (LDL) receptor and the low density lipoprotein receptor-related protein/₂-macroglobulin receptor (LRP), which are members of the same gene family. VLDL/ApoE receptor message was not detected in liver, whereas mRNAs for both LDL receptor and LRP were found in hepatic tissue. In mouse 3T3-L1 cells, VLDL/ApoE receptor mRNA was induced during the transformation of the cells into adipocytes. Expression was also detected in human choriocarcinoma cells, suggesting that at least part of the expression observed in placenta may be in trophoblasts, cells which would be exposed to maternal blood. Expression in brain may be related to high levels of ApoE expression in that organ, an observation of potential relevance to the recently hypothesized role for ApoE in late onset Alzheimer disease. Our results suggest that the putative VLDL/ApoE receptor could play a role in the uptake of triglyceride-rich lipoprotein particles by specific organs including striated and cardiac muscle and adipose tissue and in the transport of maternal lipids across the placenta. The findings presented here, together with recent observations from other laboratories, bring up the possibility that a single gene, the VLDL/ApoE receptor, may play a role in the pathogenesis of certain forms of atherosclerosis, Alzheimer disease, and obesity.The nucleotide sequence of the cDNA reported here has been deposited in GenBank Accession No. L 20470.     

Molecular cloning and sequencing of the cDNA coding for a novel regucalcin gene promoter region-related protein in rat, mouse and human liver

The molecular cloning and sequencing of the cDNA coding for a novel regucalcin gene promoter region-related protein (RGPR) was investigated using rat, mouse and human liver cDNA library with a yeast one-hybrid system and a rapid amplification of cDNA ends (RACE) method. The clone coding an unknown protein was isolated, and a novel protein was identified. This protein was termed as RGPR-p117. RGPR-p117 in rat, mouse and human liver consisted of 1058, 1051 and 1060 amino acid residues with calculated molecular mass of 117, 115 and 117 kDa and estimated pI of 5.69, 5.70 and 5.71, respectively. The homologies of amino acids among rat, mouse and human RGPR-p117 were at least 70%. RGPR-p117 had a leucine zipper motif. The expression of RGPR-p117 mRNA was found in the liver, kidney, heart, spleen, and brain of rats. The database search of the human RGPR-p117 showed that its gene consisted of at least 26 exons spanning approximately 4.1 kbp and localized on human chromosome 1q25.2. Furthermore, we found a cDNA clone which was highly identical to a front half part of the human RGPR-p117 cDNA, using the BLAST search of human RGPR-p117. This cDNA clone was a splicing variant of human RGPR-p117, which derived from human placental choriocarcinoma. Our study demonstrates that a novel gene coding RGPR-p117 is present in rat, mouse and human.     

Isolation of a specific cellular mRNA by subtractive hybridization in Theiler's virus persistent infection

Viruses change the mRNA repertoire of the tissues they infect. They add viral mRNAs and they specifically alter the expression of some host genes. These events can play important parts in pathogenesis. In principle, it should be possible to isolate viral mRNAs and to identify changes in host gene expression using subtractive hybridization. We tested this approach in the persistent infection of mouse central nervous system by Theiler's virus. A cDNA library was constructed with poly A+ RNA from infected mouse spinal cords. The library was screened with a subtracted probe. We identified one mitochondrial gene, coding for subunit 1 of cytochrome oxidase, which is overexpressed in infected tissues whereas another mitochondrial gene, URF 2, is not. Subtractive hybridization should prove to be invaluable in studying the pathogenesis of chronic human central nervous system diseases of unknown etiology.     

人类一条新的类蛋白质二硫键异构酶cDNA的克隆和表达

利用SMART技术构建了人胎脑cDNA文库，通过大规模测序筛选出一条1645bp的人类cDNA。此cDNA含有一个888bp的开放阅读框（ORF），编码一个296个氨基酸的蛋白质，预测分子量34．0KD。与目前数据库中序列比较，该cDNA编码的蛋白质与蛋白质二硫键异构酶的同源性达36％，命名为类蛋白质二硫键异构酶（PDI－L）基因，多组织Northern blot分析显示PDI－L cDNA在心、脑、肝肾等组织中均有表达，该cDNA的读框片段正确插入到改造后的pBV220表达载体中，获得了预期的表达蛋白。     

Identification of a novel membrane-associated protein expressed in neurons of the squid and rodent nervous systems

In a previous communication, we reported the isolation of a novel cDNA clone (pA6) from a library constructed from squid axonal mRNAs. The partial cDNA clone contained a unique open reading frame that encoded 84 amino acids and was complementary to a moderately abundant mRNA approximately 550-600 nucleotides in length [Chun et al., J. Neurosci. Res. 49 (1997) 144-153]. In this report, we identify the pA6 gene product, and characterize its expression in the squid and rodent brain. Results of immunoblot analyses conducted in squid, using a polyclonal antibody raised against a synthetic peptide corresponding to the C-terminus of the putative protein, established the presence of two pA6 immunoreactive proteins of approximately 14 kDa and 26 kDa in size. In contrast, mouse brain contained only a single 26-kDa immunoreactive species. In both the squid and mouse brain, the expression of pA6 appears highly selective, being detected in certain neurons but not in non-neuronal cells, as judged by both in situ hybridization and immunocytochemistry. Findings derived from light microscopic, double-label immunohistofluorescence studies indicate that pA6 protein co-localizes with prohibitin, a mitochondrial marker protein. Consistent with these results, electron microscopy localized pA6 immunoreactivity to several membrane compartments to include the outer membrane of mitochondria, as well as to the smooth endoplasmic reticulum and tubulovesicles in dendrites, axons, and axon terminals of neurons in the rat brain.Taken together, these findings indicate that pA6 is a novel, membrane-associated protein, which is expressed in the distal structural/functional domains of neurons in both the invertebrate and vertebrate nervous systems.     

Entamoeba histolytica: cloning and characterization of actin cDNA

In order to study gene expression in the human parasite Entamoeba histolytica, a cDNA library of E. histolytica strain 200:NIH was constructed using the phage vector lambda gt10. Three cDNA clones (A, B and C) were selected for further analysis. Each of the three clones hybridized to a distinct mRNA. Two of these mRNAs were translated in vitro after hybrid selection, and yielded distinct translation products. One of these mRNAs, selected by hybridization to clone A, encodes the most abundantly expressed protein in E. histolytica. DNA sequence analysis of this cDNA clone identified the DNA as that encoding actin. The deduced amino acid sequence of E. histolytica actin resembles both cytoplasmic and muscle actins and has an unusual N-terminal glycine residue. We have shown that a family of actin genes is present in E. histolytica. Six different E. histolytica actin clones were obtained from a lambda gt10 genomic library using subcloned cDNA probes. Southern analysis of three different E. histolytica strains (200:NIH, Rhaman, and HM-1:IMSS) revealed at least four different actin genes. Strain HM-1:IMSS, however, differs by the presence of an additional actin gene.     

Postmortem studies of the effect of anti-inflammatory drugs on Alzheimer-type pathology and associated inflammation

Examining postmortem tissue is the most direct way of evaluating the effect of antemortem drug use on the pathological processes believed to be important in Alzheimer’s disease (AD). A small number of studies have recently been published in which data from human autopsy tissue and animal models provides important insight into the mechanisms by which anti-inflammatory (AI) agents may protect against AD. These indicate that certain classes of AI drugs may be capable of reducing the chronic inflammation which is consistently seen in AD brain tissue. In addition, a recent study using a transgenic mouse model of AD, suggests that AI therapy may also influence the accumulation of senile plaques and dystrophic neurites. The results of these and future postmortem studies will be invaluable in the development of optimum treatment strategies.     

cDNA cloning and chromosome mapping of the human Fe65 gene: interaction of the conserved cytoplasmic domains of the human beta-amyloid precursor protein and its homologues with the mouse Fe65 protein

Using the yeast two hybrid system, a mouse embryo cDNA library was screened for proteins that interact with the C-terminus of the human beta-amyloid precursor protein (beta PP). A fusion protein was identified that interacts specifically with the cytoplasmic domain of beta PP and does not interact with the beta-amyloid region. The protein encoded by this partial mouse cDNA is identical to the C-terminus of the rat Fe65 protein. This mouse protein also interacts with the homologous C-terminal domains of the mouse amyloid precursor-like proteins, APLP1 and APLP2. These conserved cytoplasmic regions contain a common amino acid motif, Asn-Pro-Thr-Tyr, which has previously been shown to influence both the secretion and internalization of beta PP. Fe65 has been implicated in regulatory and cell signaling mechanisms because it contains two different motifs involved in protein binding, a WW domain (a variant of Src homology 3 domains) and a phosphotyrosine interaction domain (PID). Interestingly, the PID domain binds to the same motif present in the conserved cytoplasmic domains of the beta PP and beta PP-like proteins. RNA analyses reveal that Fe65 is predominantly expressed in brain and in the regions most affected by Alzheimer's disease (AD)-associated neuropathology. The human Fe65 mRNA was cloned from a fetal brain cDNA library. The message encodes a protein of 735 amino acids that is 95% identical to the rat Fe65 protein. The human Fe65 gene was mapped on human metaphase chromosomes to band 11p15 using fluorescence in situ hybridization.      

阿尔茨海默病小鼠脑组织长链非编码RNA与信使RNA表达谱及调控网络的分析

目的 分析阿尔茨海默病（AD）小鼠脑组织长链非编码RNA（LncRNA）和信使RNA（mRNA）表达谱,构建竞争内源性RNA（ceRNA）调控网络,探讨差异表达LncRNA在AD发病机制中的潜在作用。方法 选取3只10月龄雄性APP/PS1转基因小鼠作为AD组,3只年龄及体质量相匹配的普通C57小鼠作为对照组。使用基因芯片技术检测2组小鼠脑组织LncRNA和mRNA的表达,筛选出差异表达的LncRNA和mRNA。对部分差异表达的LncRNA进行实时定量聚合酶链反应（qRT-PCR）。对差异表达的mRNA进行基因本体论（GO）和京都基因、基因组百科全书（KEGG）通路分析。随机挑选6个差异表达LncRNA构建ceRNA网络,进行AD的靶基因功能预测分析。结果 与对照组相比,AD组小鼠脑组织差异表达1.5倍以上的LncRNA有933个,其中上调222个,下调711个;差异表达1.5倍以上的mRNA有529个,其中上调189个,下调340个。qRT-PCR检测结果显示,AD组与对照组比较,7个差异表达的LncRNA上调或下调趋势与基因芯片结果一致,差异均有统计学意义（P值均<0.05）。GO和KEGG通路分析结果显示,差异表达基因主要参与氨基酸代谢、炎症反应和免疫反应。ceRNA调控网络靶基因的功能富集分析显示,LncRNA在胰岛素抵抗以及糖尿病并发症中的AGE-RAGE信号通路中显著富集。结论 AD小鼠脑组织LncRNA表达谱发生显著变化,由LncRNA Dgkb、Svip等构建的ceRNA调控网络有助于增进对AD发病分子机制的研究,差异表达的LncRNA或通路有可能成为潜在的治疗靶点。